REFERENCES
- Fang YX, Wang YB, Shi J, Liu ZM, Lu L. Recent trends in drug abuse in China: A review. Acta Pharmacol Sin 2006; 27:140–144.
- National Narcotic Control Commission. The registered drug users in China reach 1.33 million at 2009. Available at http://www.mps.gov.cn/n16/n1252/n1897/n2872/2327636.html 2010.02.01
- Liu Z, Lian Z, Zhao C. Drug use and HIV/AIDS in China. Drug Alcohol Rev 2006; 25(2):173–175.
- Monitoring the AIDS Pandemic Network (MAP). Drug Injection and HIV/AIDS in Asia – MAP Report. Geneva: MAP, 2005.
- Ma Y, Li ZZ, Zhang KX. Identification of HIV infection among drug users in China. Chin J Epidemiol 1990; 11:184–185.
- Rhodes T, Stimson GV, Crofts N, Ball A, Dehne K, Khodakevich L. Drug injecting, rapid HIV spread, and the “risk environment”: Implications for assessment and response. AIDS 1999; 13(Suppl. A):S259–S269.
- State Council AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care. Beijing: State Council AIDS Working Committee Office, 2007.
- Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18:352–358.
- CDC, Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998, 47:1–39.
- Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Pub Health 1996; 86:655–661.
- Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction 2010; 105(2):311–318.
- Du WJ, Xiang YT, Wang ZM, Chi Y, Zheng Y, Luo XN, Cai ZJ, Ungvari GS, Gerevich J. Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug Alcohol Depend 2008; 94(1–3):158–164.
- Pang L, Hao Y, Mi G, Wang C, Luo W, Rou K, Li J, Wu Z. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007; 21(Suppl. 8):S103–S107.
- Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 2009; 20:399–405.
- Liu YH, Yan L, Hu Y, Liu XC. The HIV, HCV and syphilis infection among 486 drug users in Beijing. Dis Surveill 2007; 22:10–12.
- Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis. Publ Health 2008; 122:990–1003.
- Liu ZM, Lian Z, Mu Y, Zhou WH, Wang YZ, Guli ZH, Sun F, Liu JX, Xiao ZC, Tie NG, Cao JQ, Cai ZJ. Knowledge and risk behavior on HIV/AIDS among drug addicts in four areas in China. Chin J Drug Depend 2001; 10(1):48–52.
- Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: Epidemiology, natural history, therapeutic options and clinical management. Infection 2004; 32:33–46.